Nutrigenomics Therapy of Hepatisis C Virus Induced-hepatosteatosis

BMC Gastroenterology

Volumn 10, Issue , 2010, Pages

  Liu, Qing ^a,c   Bengmark, Stig ^b   Qu, Shen ^a,b  

^a TONGJI UNIVERSITY   (China)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA TOCOPHEROL; ARACHIDONIC ACID; BETA CAROTENE; CORE PROTEIN; CYCLOSPORIN; DOCOSAHEXAENOIC ACID; ERGOCALCIFEROL; FLUINDOSTATIN; GLITAZONE DERIVATIVE; ICOSAPENTAENOIC ACID; LINOLEIC ACID; MESSENGER RNA; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; POLYUNSATURATED FATTY ACID; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; VIRUS RNA; FATTY ACID;

ANTIVIRAL ACTIVITY; DIET SUPPLEMENTATION; FATTY LIVER; FOOD DRUG INTERACTION; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; HEPATITIS C VIRUS; HUMAN; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; NONHUMAN; NUTRIGENOMICS; REVIEW; RNA REPLICATION; TREATMENT RESPONSE; VIRUS REPLICATION; DRUG EFFECT; GENETICS; HEPATITIS C; PATHOPHYSIOLOGY; PHYSIOLOGY; VIROLOGY;

FATTY ACIDS, NONESTERIFIED; FATTY LIVER; HEPACIVIRUS; HEPATITIS C; HUMANS; LIPID METABOLISM; NUTRIGENOMICS; VIRAL CORE PROTEINS; VIRUS REPLICATION;

EID: 77954314778     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-10-49     Document Type: Review

References (57)

1. Ferguson LR, Shelling AN, Lauren D. For Nutrigenomics New Zealand. Nutrigenomics and gut health: meeting report from an international conference in Auckland, New Zealand. Genes Nutr 2007, 2:157-60. 10.1007/s12263-007-0046-1, 2474923, 18850170.
2. Ferguson LR, Peterman I, Hübner C, Philpott M, Shellin AN. Uncoupling gene-diet interactions in inflammatory bowel disease (IBD). Genes Nutr 2007, 2:71-3. 10.1007/s12263-007-0012-y, 2474911, 18850145.
3. Astley SB. An introduction to nutrigenomics developments and trends. Genes Nutr 2007, 2:11-3. 10.1007/s12263-007-0011-z, 2474912, 18850130.
4. Jonsson JR, Barrie HD, O'Rourke P, Clouston AD, Powell EE. Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C. Hepatology 2008, 48:80-7. 10.1002/hep.22311, 18571785.
5. Loguercio C, Federico A, Masarone M, Torella R, Blanco CD, Persico M. The Impact of Diet on Liver Fibrosis and on Response to Interferon Therapy in Patients with HCV-Related Chronic Hepatitis. Am J Gastroentero 2008, 103:3159-66.
6. Asselah T, Rubbia-Brandt L, Marcellin P, Negro F. Steatosis in chronic hepatitis C: why does it really matter?. Gut 2006, 55:123-130. 10.1136/gut.2005.069757, 1856395, 16344578.
7. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002, 36:S35-S46. 10.1002/hep.1840360706, 12407575.
8. Bartenschlager R, Sparacio S. Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture. Virus Res 2007, 127:195-207. 10.1016/j.virusres.2007.02.022, 17428568.
9. Perlemuter G, Sabile A, Letteron P, Vona G, Topilco A, Chrétien Y, Koike K, Pessayre D, Chapman J, Barba G, Bréchot C. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J 2002, 16:185-94. 10.1096/fj.01-0396com, 11818366.
10. Lettéron P, Sutton A, Mansouri A, Fromenty B, Pessayre D. Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. Hepatology 2003, 38:133-40. 10.1053/jhep.2003.50309, 12829995.
11. Enjoji M, Nakamuta M, Kinukawa N, Sugimoto R, Noguchi K, Tsuruta S, Iwao M, Kotoh K, Iwamoto H, Nawata H. Beta-lipoproteins influence the serum level of hepatitis C virus. Med Sci Monit 2000, 6:841-844.
12. Petit JM, Benichou M, Duvillard L, Jooste V, Bour JB, Minello A, Verges B, Brun JM, Gambert P, Hillon P. HCV-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis and liver fibrosis. Am J Gastroenterol 2003, l98:1150-1154.
13. Lerat H, Kammoun HL, Hainault I, Mérour E, Higgs MR, Callens C, Lemon SM, Foufelle F, Pawlotsky JM. Hepatitis C virus proteins induce lipogenesis and defective triglyceride secretion in transgenic mice. J Biol Chem 2009, 284:33466-74. 10.1074/jbc.M109.019810, 19808675.
14. Domitrovich AM, Felmlee DJ, Siddiqui A. Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion. J Biol Chem 2005, 280:39802-8. 10.1074/jbc.M510391200, 16203724.
15. Mirandola S, Realdon S, Iqbal J, Gerotto M, Dal Pero F, Bortoletto G, Marcolongo M, Vario A, Datz C, Hussain MM, Alberti A. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis. Gastroenterology 2006, 130:1661-9. 10.1053/j.gastro.2006.02.035, 16697730.
16. Shimano H. Sterol regulatory element-binding protein family as global regulators of lipid synthetic genes in energy metabolism. Vitam Horm 2002, 65:167-94. full_text, 12481547.
17. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002, 109:1125-31. 150968, 11994399.
18. Shimano H. Sterol regulatory element-binding protein family as global regulators of lipid synthetic genes in energy metabolism. Vitam Horm 2002, 65:167-94. full_text, 12481547.
19. Barrera G, Toaldo C, Pizzimenti S, Cerbone A, Pettazzoni P, Dianzani MU, Ferretti C. The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products. PPAR Res 2008, 2008:524671. 2443425, 18615196.
20. Cho MC, Lee K, Paik SG, Yoon DY. Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders. PPAR Res 2008, 2008:679137. 2430035, 18566691.
21. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999, 20:649-688. 10.1210/er.20.5.649, 10529898.
22. Cheng Y, Dharancy S, Malapel M, Desreumaux P. Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A. World J Gastroenterol 2005, 11:7591-6.
23. Jump DB, Botolin D, Wang Y, Xu J, Demeure O, Christian B. Docosahexaenoic acid (DHA) and hepatic gene transcription. Chem Phys Lipids 2008, 153:3-13. 10.1016/j.chemphyslip.2008.02.007, 2430187, 18343222.
24. Castera L, Chouteau P, Hezode C. Hepatitis C Virus-Induced Hepatocellular Steatosis. Am J Gastroenterol 2005, 100:711-15. 10.1111/j.1572-0241.2005.40898.x, 15743372.
25. Tanaka N, Moriya K, Kiyosawa K, Koike K, Gonzalez FJ, Aoyama T. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. J Clin Invest 2008, 118:683-94. 2176192, 18188449.
26. Waris G, Felmlee DJ, Negro F, Siddiqui A. Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J Virol 2007, 81:8122-30. 10.1128/JVI.00125-07, 1951320, 17507484.
27. Bernsmeier C, Duong FH, Christen V, Pugnale P, Negro F, Terracciano L, Heim MH. Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C. J Hepatol 2008, 49:429-40. 10.1016/j.jhep.2008.04.007, 18486982.
28. Sheikh MY, Choi J, Qadri I, Friedman JE, Sanyal AJ. Hepatitis C virus infection: molecular pathways to metabolic syndrome. Hepatology 2008, 47:2127-33. Review., 10.1002/hep.22269, 18446789.
29. Yano M, Ikeda M, Abe K, Dansako H, Ohkoshi S, Aoyagi Y, Kato N. Comprehensive Analysis of the Effects of Ordinary Nutrients on Hepatitis C Virus RNA Replication in Cell Culture. Antimicrob Agents Chemother 2007, 51:2016-27. 10.1128/AAC.01426-06, 1891399, 17420205.
30. Appel N, Schaller T, Penin F, Bartenschlager R. From structure to function: new insights into hepatitis C virus RNA replication. J Biol Chem 2006, 281:9833-9836. 10.1074/jbc.R500026200, 16407182.
31. Fillebeen C, Rivas-Estilla AM, Bisaillon M, Ponka P, Muckenthaler M, Hentze MW, Koromilas AE, Pantopoulos K. Iron inactivates the RNA polymerase NS5B and suppresses subgenomic replication of hepatitis C virus. J Biol Chem 2005, 280:9049-57. 10.1074/jbc.M412687200, 15637067.
32. Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology 2002, 36:S237-44. 10.1002/hep.1840360730, 12407599.
33. Ikeda M, Abe K, Dansako H, Nakamura T, Naka K, Kato N. Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system. Biochem Biophys Res Commun 2005, 329:1350-9. 10.1016/j.bbrc.2005.02.138, 15766575.
34. Ikeda M, Abe K, Yamada M, Dansako H, Naka K, Kato N. Different anti-HCV profiles of statins and their potential for combination therapy with interferon. Hepatology 2006, 44:117-25. 10.1002/hep.21232, 16799963.
35. Ikeda M, Yi M, Li K, Lemon SM. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J Virol 2002, 76:2997-3006. 10.1128/JVI.76.6.2997-3006.2002, 135991, 11861865.
36. Kapadia SB, Chisari FV. Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc Natl Acad Sci USA 2005, 102:2561-6. 10.1073/pnas.0409834102, 549027, 15699349.
37. Sealls W, Gonzalez M, Brosnan MJ, Black PN, DiRusso CC. Dietary polyunsaturated fatty acids (C18: 2 omega6 and C18: 3 omega3) do not suppress hepatic lipogenesis. Biochim Biophys Acta 2008, 1781:406-14.
38. Leclercq S, Skrzypski J, Courvoisier A, Gondcaille C, Bonnetain F, André A, Chardigny JM, Bellenger S, Bellenger J, Narce M, Savary S. Effect of dietary polyunsaturated fatty acids on the expression of peroxisomal ABC transporters. Biochimie 2008, 90:1602-7. 10.1016/j.biochi.2008.05.022, 18585430.
39. Kim HJ, Lee KT, Park YB, Jeon SM, Choi MS. Dietary docosahexaenoic acid-rich diacylglycerols ameliorate hepatic steatosis and alter hepatic gene expressions in C57BL/6J-Lep(ob/ob) mice. Mol Nutr Food Res 2008, 52:965-73. 10.1002/mnfr.200700315, 18481331.
40. Nakamura MT, Nara TY. Gene regulation of mammalian desaturases. Biochem Soc Trans 2002, 30:1076-9. Review., 10.1042/BST0301076, 12440976.
41. Ren B, Thelen AP, Peters JM, Gonzalez FJ, Jump DB. Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha. J Biol Chem 1997, 272:26827-32. 10.1074/jbc.272.43.26827, 9341113.
42. Dallongeville J, Baugé E, Tailleux A, Peters JM, Gonzalez FJ, Fruchart JC, Staels B. Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil. J Biol Chem 2001, 276:4634-9. 10.1074/jbc.M008809200, 11050100.
43. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999, 20:649-88. 10.1210/er.20.5.649, 10529898.
44. Ye JM, Doyle PJ, Iglesias MA, Watson DG, Cooney GJ, Kraegen EW. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation. Diabetes 2001, 50:411-7. 10.2337/diabetes.50.2.411, 11272155.
45. Guerre-Millo M, Gervois P, Raspé E, Madsen L, Poulain P, Derudas B, Herbert JM, Winegar DA, Willson TM, Fruchart JC, Berge RK, Staels B. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J Biol Chem 2000, 275:16638-42. 10.1074/jbc.275.22.16638, 10828060.
46. Jump DB. The biochemistry of n-3 polyunsaturated fatty acids. J Biol Chem 2002, 277:8755-8. 10.1074/jbc.R100062200, 11748246.
47. Deckelbaum RJ, Worgall TS, Seo T. n-3 fatty acids and gene expression. Am J Clin Nutr 2006, 83:1520-1525.
48. Johnson RA, Hamilton JA, Worgall TS, Deckelbaum RJ. Free fatty acids modulate intermembrane trafficking of cholesterol by increasing lipid mobilities: novel 13C NMR analyses of free cholesterol partitioning. Biochemistry 2003, 42:1637-45. 10.1021/bi0264465, 12578377.
49. Worgall TS, Johnson RA, Seo T, Gierens H, Deckelbaum RJ. Unsaturated fatty acid-mediated decreases in sterol regulatory element-mediated gene transcription are linked to cellular sphingolipid metabolism. J Biol Chem 2002, 277:3878-85. 10.1074/jbc.M102393200, 11707431.
50. Rosenwald AG, Machamer CE, Pagano RE. Effects of a sphingolipid synthesis inhibitor on membrane transport through the secretory pathway. Biochemistry 1992, 31:3581-90. 10.1021/bi00129a005, 1567816.
51. Yao ZM, Vance DE. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J Biol Chem 1988, 263:2998-3004.
52. Lee GS, Yan JS, Ng RK, Kakar S, Maher JJ. Polyunsaturated fat in the methionine-choline-deficient diet influences hepatic inflammation but not hepatocellular injury. J Lipid Res 2007, 48:1885-96. 10.1194/jlr.M700181-JLR200, 17526933.
53. Rinella ME, Green RM. The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J Hepatol 2004, 40:47-51. 10.1016/j.jhep.2003.09.020, 14672613.
54. Peter JR, Moffat JN, Brian RW. A Choline-Deficient Diet Exacerbates Fatty Liver but Attenuates Insulin Resistance and Glucose Intolerance in Mice Fed a High-Fat Diet. Diabetes 2006, 55:2015-2020. 10.2337/db06-0097, 16804070.
55. Dela Peña A, Leclercq I, Field J, George J, Jones B, Farrell G. NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. Gastroenterology 2005, 129:1663-74. 10.1053/j.gastro.2005.09.004, 16285964.
56. Larter CZ, Yeh MM, Cheng J, Williams J, Brown S, dela Pena A, Bell-Anderson KS, Farrell GC. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation. J Gastroenterol Hepatol 2008, 23:267-75. 10.1111/j.1440-1746.2007.05157.x, 17868330.
57. Hussein O, Grosovski M, Lasri E, Svalb S, Ravid U, Assy N. Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats. World J Gastroenterol 2007, 13:361-8.